Public Employees Retirement System of Ohio Buys Shares of 42,244 Takeda Pharmaceutical Company Limited (NYSE:TAK)

Public Employees Retirement System of Ohio acquired a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 42,244 shares of the company's stock, valued at approximately $601,000.

Other hedge funds have also made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its stake in shares of Takeda Pharmaceutical by 38.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company's stock valued at $43,000 after purchasing an additional 859 shares during the last quarter. BNP Paribas Financial Markets lifted its position in Takeda Pharmaceutical by 416.0% in the third quarter. BNP Paribas Financial Markets now owns 3,220 shares of the company's stock valued at $46,000 after buying an additional 2,596 shares during the last quarter. Smithfield Trust Co increased its position in shares of Takeda Pharmaceutical by 76.9% during the third quarter. Smithfield Trust Co now owns 3,428 shares of the company's stock valued at $49,000 after acquiring an additional 1,490 shares during the last quarter. Erste Asset Management GmbH purchased a new stake in shares of Takeda Pharmaceutical in the 3rd quarter valued at approximately $52,000. Finally, Hexagon Capital Partners LLC lifted its holdings in shares of Takeda Pharmaceutical by 34.3% in the 3rd quarter. Hexagon Capital Partners LLC now owns 4,419 shares of the company's stock worth $63,000 after acquiring an additional 1,129 shares during the last quarter. Institutional investors and hedge funds own 9.17% of the company's stock.

Takeda Pharmaceutical Trading Up 0.7 %

TAK traded up $0.09 during mid-day trading on Friday, hitting $13.10. 1,848,702 shares of the stock were exchanged, compared to its average volume of 1,830,433. The company has a market cap of $41.68 billion, a PE ratio of 22.59, a PEG ratio of 0.25 and a beta of 0.51. The company has a current ratio of 1.28, a quick ratio of 0.77 and a debt-to-equity ratio of 0.64. The firm's fifty day moving average is $13.70 and its two-hundred day moving average is $13.87. Takeda Pharmaceutical Company Limited has a 1-year low of $12.57 and a 1-year high of $15.08.

Takeda Pharmaceutical Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.